Latest Conference Articles

With new medications and therapies being developed for a variety of conditions, a consistent message from the medical community can help move treatment forward.

Results from the TECOS trial indicate patients with type 2 diabetes and cardiovascular disease treated with sitagliptin are not at higher risk for cardiovascular events or hospitalization.

The American Medical Association is calling for full disclosure of chemicals used in hydraulic fracturing, citing a need for further study about potential public health impacts of the practice.

As the market for Hepatitis C treatments continues to grow, the American Medical Association is calling for the government and payers to do more to ensure new therapies are affordable.

There can be significant obstacles for healthcare professionals in the United States treating Hispanic and Latino patients, particularly when a language barrier is involved.

A flying lacrosse ball weighs more than 5 lbs and goes about 60 mph in the girls' version of the sport. Despite objections that there have been no definitive studies showing wearing headgear protects players, the AMA wants sports authorities to require girls teams to wear helmets.

The American Medical Association's House of Delegates discussed the collision of physicians' free speech rights with patients' rights to privacy Monday. They also weighed whether to support universal background checks for gun purchases and distributing NRA gun safety literature to patients.

Diabetes is an ever growing problem in the latino community which also continues to grow in the United States. Addressing the condition in these patients is sometimes about more than just knowing the medications they require.

The new president of the American Medical Association is the group's youngest president in 160 years. He plans to focus on public health, revamping medical education, and reducing burnout during his term.

The violent death of Boston, MA cardiac surgeon Michael Davidson Jan. 20 was much on the minds of physicians at the AMA's meeting in Chicago. Davidson was honored in a memorial and the delegates resolved to lobby for ways to protect physicians from such assaults.

On Tuesday, the American Medical Association's House of Delegates debated the wisdom of forming a so-called Super PAC to help influence elections. However, the idea raised a number of concerns.

Although patients with diabetes who were at high risk for cardiovascular events did not benefit from treatment with lixisenatide, results from the ELIXA study showed that the drug is safe in this population.

Study results show combination treatment with empagliflozin and linagliptin effectively reduced HbA1c in patients with type 2 diabetes mellitus.

The American Medical Association on Monday called the military's policy of excluding transgender service members "out of date."

Despite assurances from the Obama administration that physicians who provide marijuana to patients for therapeutic use in states where that is legal will not face federal prosecution, the AMA is calling for a law. They want an ironclad guarantee these doctors will have legal immunity.

The mobile health application industry continues to grow in the US, even though most of the apps aren't clinically proven. Now, the American Medical Association says it will work to come up with best practices for medical app developers.

In what could be a tough political fight, members of the American Medical Association's House of Delegates today passed a resolution authorizing a campaign to get all states to ban philosophical and religious beliefs as grounds for opting out of routine vaccinations. Only medical exemptions should be allowed, the delgates agreed.

As the diabetes epidemic continues to grow doctors are being faced with the task of stopping or reversing the trend.

For patients with diabetes controlling their condition is largely in their hands. How they work the process can determine their overall quality of life.

Alogliptin appears to slow the progression of carotid atherosclerosis in patients with type 2 diabetes mellitus.

As the healthcare landscape has changed in recent years everyone from patients to doctors to pharmaceutical companies have had to change along with it.

The FDA rightfully cracked down on compounding pharmacies under a 2013 law brought on by 64 deaths traced to contaminated drugs at a dirty compounding facility. But physicians are concerned the FDA's new powers could end in-office compounding for individual patients, a common practice in many medical specialities.

The Congressional repeal of the Medicare sustained growth rate formula for calculating doctors' payments has the American Medical Association energized and ready to push for more reform. First up is trying to delay or stop the implementation of a new billing code system the group says will be costly for its members. It's known as ICD-10.

When blood glucose levels prove difficult to control in patients with type 2 diabetes mellitus, it may be time to consider adding a third drug to the treatment regimen.

With a complicated condition like diabetes there is more to treatment than finding the right medication for patients. Providing the information they need and direction to help in their daily lives is also a key part of the overall picture.

There are a substantial number of factors physicians must take into consideration before starting a patient with type 2 diabetes mellitus on a particular treatment path. According to results from a recent study, the effectiveness of one of the most popular diabetes medications may be dependent on a patient's race or ethnicity.

With multiple factors hurting patients' chances of reaching type 2 diabetes treatment goals – including a lack of timely follow-up appointments and yo-yo blood glucose (A1C) levels – a respected physician recently advised a major shift in treatment, especially early on in the progressive disease.

Even adults with diabetes may be injecting insulin incorrectly which could put them at higher risk for additional conditions, according to lead author Paula M. Trief, PhD, of SUNY Upstate Medical Center.

With more than 10000 people in Boston for the American Diabetes Association's Scientific Sessions the event provides a chance for some of the top minds in the field to share information.

With so many people affected by diabetes finding the right treatment for the individual patients is becoming a key factor in care.